Real-World Effectiveness of SGLT2 Inhibitors Vs Metformin As First-Line Therapy in Type 2 Diabetes
Document Type
Abstract
Publication Date
5-7-2023
Keywords
oregon; cards; cards abstracts
Abstract
Presented at ISPOR—The Professional Society for Health Economics and Outcomes Research Annual Meeting, May 7-10, 2023, Boston, MA
Clinical Institute
Cardiovascular (Heart)
Department
Cardiology
Recommended Citation
Rodriguez, PJ; Gluckman, Tyler; and See full list of authors in comments, "Real-World Effectiveness of SGLT2 Inhibitors Vs Metformin As First-Line Therapy in Type 2 Diabetes" (2023). Articles, Abstracts, and Reports. 8409.
https://digitalcommons.providence.org/publications/8409
Comments
Rpdriguez PJ, Gratzl S, Lee R, Gilson S, Smits P, Stucky N, Gluckman TJ